XOMA Royalty (XOMA) Amortization of Deferred Charges (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Amortization of Deferred Charges came in at $332000.0 in Q1 2026, down 22.25% year-on-year from $427000.0 in Q1 2025, and up 33.33% quarter-over-quarter from $249000.0 in Q4 2025.

XOMA Royalty (XOMA) Amortization of Deferred Charges (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Amortization of Deferred Charges across 14 years of filings, most recently posting $332000.0 for Q1 2026.

  • Amortization of Deferred Charges for Q1 2026 came in at $332000.0, down 22.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 12.3% YoY), and the FY2025 annual result was $1.4 million, up 2.59% from the prior year.
  • Amortization of Deferred Charges came in at $332000.0 for Q1 2026 at XOMA Royalty, up from $249000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $427000.0 in Q1 2025 to a low of $249000.0 in Q4 2025.
  • The 3-year median for Amortization of Deferred Charges is $332000.0 (2026), against an average of $340777.8.
  • Peak annual rise in Amortization of Deferred Charges reached 39.54% in 2025, while the deepest fall reached 29.66% in 2025.
  • XOMA Royalty's Amortization of Deferred Charges stood at $354000.0 in 2024, then dropped by 29.66% to $249000.0 in 2025, then surged by 33.33% to $332000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $332000.0 (Q1 2026), $249000.0 (Q4 2025), and $387000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 XOMA Royalty 5.48 Mn -60.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 332,000.00
Mar 31, 2026 332,000.00
Dec 31, 2025 249,000.00
Dec 31, 2025 249,000.00
Sep 30, 2025 387,000.00
Sep 30, 2025 387,000.00
Jun 30, 2025 322,000.00
Jun 30, 2025 322,000.00
Mar 31, 2025 427,000.00
Mar 31, 2025 427,000.00
Dec 31, 2024 354,000.00
Dec 31, 2024 354,000.00
Sep 30, 2024 408,000.00
Sep 30, 2024 408,000.00
Jun 30, 2024 282,000.00
Jun 30, 2024 282,000.00
Mar 31, 2024 306,000.00
Mar 31, 2024 306,000.00
Jun 30, 2021 73,000.00
Jun 30, 2021 73,000.00